Sector-focused private equity firm DW Healthcare Partners has made five hires and two promotions in the wake of closing its oversubscribed third fund on $265m.
Eric Keen, pictured, has been promoted to principal and Sameer Mathur to vice president in the firm’s new Toronto office, while Philip Smith has been hired as vice president and Karen jones as investment sourcing director.
Eric Moore, Alex Aptekman and Philip Edmunds have all been taken on as associates as the firm looks to up its investing following the close of DWHP III in February.
Keen has spent more than ten years in private equity, working with the The Riverside Company and Norwest Equity Partners before joining DWHP.
Mathur, who was hired by the firm in 2009, previously worked as an associate at Francisco Partners and has also been a consultant for Bain & Company.
Smith spent the past three years working for RoundTable Healthcare Partners, while Jones has 25 years of experience including acquisitions, investment management and healthcare technology consulting.
Her previous employers include Biosense Webster, Johnson & Johnson Medical Products, Healthwise Diagnostics and the Ontario Teachers’ Pension Plan Board.
DWHP co-founder and managing partner Andrew Carragher said, “We are fortunate, with the launch of our third healthcare fund, to have the opportunity to recognize individual success stories and achievements within our firm.
“We have also been able to hire talented new professionals with valuable and relevant experience in both the private equity and healthcare industries.”
The hires bring DWHP’s team to 11 investment and operating professionals and three deal-origination staff.
DWHP opened its new Toronto office in conjunction with closing the third fund, allowing it to cover the east coast of the US and Canada more efficiently than it would have been able to from its existing Utah base.
The firm exceeded its original $250m target for Fund III, and previously held a $150m first closing in March last year.
It has already tapped the fund for $80m to invest in Z-Medica, the Health & Safety Institute and Med-Pharmex.
Copyright © 2013 AltAssets